Anavex Life Sciences Reports Fiscal 2020 Third Quarter Financial Results And Provides Business Updates

 Anavex Life Sciences Reports Fiscal 2020 Third Quarter Financial Results And Provides Business Updates Conference Call and Webcast Today at 11:00 a.m. ET   NEW YORK – August 6, 2020 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders…